News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
330,411 Results
Type
Article (19777)
Company Profile (128)
Press Release (310506)
Section
Business (105327)
Career Advice (876)
Deals (18525)
Drug Delivery (93)
Drug Development (50704)
Employer Resources (79)
FDA (7668)
Job Trends (7730)
News (185757)
Policy (17321)
Tag
Academia (726)
Alliances (27810)
Alzheimer's disease (597)
Antibody-drug conjugate (ADC) (71)
Approvals (7652)
Artificial intelligence (105)
Bankruptcy (171)
Best Places to Work (5544)
Biosimilars (74)
Breast cancer (92)
Cancer (808)
Cardiovascular disease (78)
Career advice (708)
Cell therapy (120)
Clinical research (42208)
Collaboration (348)
Compensation (107)
COVID-19 (1085)
C-suite (93)
Data (825)
Diabetes (113)
Diagnostics (1760)
Drug pricing (101)
Earnings (38434)
Employer resources (73)
Events (48038)
Executive appointments (330)
FDA (8061)
Funding (234)
Gene therapy (107)
GLP-1 (531)
Government (1810)
Healthcare (5887)
Infectious disease (1142)
Inflammatory bowel disease (74)
Interviews (115)
IPO (7346)
Job creations (2431)
Job search strategy (646)
Layoffs (262)
Legal (4094)
Lung cancer (127)
Manufacturing (158)
Medical device (1968)
Medtech (1971)
Mergers & acquisitions (11326)
Metabolic disorders (395)
Neuroscience (828)
NextGen: Class of 2025 (2353)
Non-profit (907)
Northern California (847)
Obesity (253)
Opinion (180)
Patents (93)
People (33178)
Pharmaceutical (73)
Phase I (13197)
Phase II (17857)
Phase III (14356)
Pipeline (399)
Policy (82)
Postmarket research (1618)
Preclinical (4597)
Radiopharmaceuticals (158)
Rare diseases (187)
Real estate (3173)
Regulatory (12310)
Research institute (816)
Resumes & cover letters (138)
Southern California (785)
Startups (2006)
United States (7838)
Vaccines (230)
Weight loss (210)
Date
Last 7 days (340)
Last 30 days (1352)
Last 365 days (17452)
2025 (1385)
2024 (17693)
2023 (19664)
2022 (25903)
2021 (26691)
2020 (24896)
2019 (20074)
2018 (15601)
2017 (17267)
2016 (16209)
2015 (18810)
2014 (14790)
2013 (12557)
2012 (13491)
2011 (13819)
2010 (12742)
Location
Africa (406)
Asia (24698)
Australia (3183)
California (1951)
Canada (909)
China (230)
Colorado (78)
Connecticut (77)
Europe (50938)
Florida (312)
Illinois (198)
Indiana (144)
Japan (85)
Maryland (289)
Massachusetts (1644)
Minnesota (109)
New Jersey (761)
New York (570)
North Carolina (413)
Northern California (847)
Ohio (70)
Pennsylvania (458)
South America (605)
Southern California (785)
Texas (256)
Washington State (172)
330,411 Results for "asahi kasei pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Asahi Kasei Pharma Strengthens Global Reach with Exclusive License Agreement for anti-CX3CR1 Antibody
December 11, 2024
·
3 min read
Deals
Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company
Asahi Kasei Corp. announces that it will offer the shareholders of Calliditas Therapeutics AB to acquire the shares of the pharmaceutical company Calliditas for the purpose of making Calliditas a wholly-owned subsidiary of Asahi Kasei through a voluntary tender offer for Calliditas.
May 28, 2024
·
7 min read
Pharm Country
Asahi Kasei Launches Membrane System to Produce Water for Injection
Asahi Kasei has announced that in April 2024 it began selling a membrane system to produce WFI, a type of sterile water that is used for the preparation of injections.
June 13, 2024
·
3 min read
Business
Asahi Kasei starts operation of multi-module hydrogen pilot plant in Kawasaki
The Japanese technology company Asahi Kasei is further accelerating its hydrogen business activities.
May 14, 2024
·
5 min read
Business
Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.
April 11, 2024
·
5 min read
Business
Asahi Kasei Medical and AW Technologies enter exclusive distribution agreement for TrachFlush in Japan
AW Technologies and Asahi Kasei Medical, a core operating company of the Asahi Kasei Group, have entered into an exclusive distribution agreement in Japan for AW Technologies’ TrachFlush™ device.
April 3, 2024
·
3 min read
Deals
Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation
The Board of Directors of Calliditas Therapeutics AB unanimously recommends that the shareholders and holders of American Depositary Shares of Calliditas Therapeutics AB accept the public tender offer by Asahi Kasei Corporation.
May 28, 2024
·
24 min read
Pharm Country
Crystal IS and Asahi Kasei have achieved 99% usable area on 100 mm bulk aluminum nitride substrate
Crystal IS, an Asahi Kasei company, announced the successful serial production of 100 mm diameter single-crystal aluminum nitride substrates with 99% usable area, based on current requirements for UVC LEDs, with manufacturing to take place in the United States.
June 12, 2024
·
3 min read
Press Releases
Asahi Kasei Medical launches Planova™ FG1 next-generation virus removal filter
October 23, 2024
·
3 min read
Deals
Asahi Kasei Offers $1.1B for Swedish Pharma Calliditas Therapeutics
The potential purchase by the Japanese conglomerate could secure access to Calliditas’ IgA nephropathy therapy Tarpeyo, which won the FDA’s full approval in December 2023.
May 28, 2024
·
2 min read
·
Tyler Patchen
1 of 33,042
Next
